ANEBULO PHARMACEUTICALS INC (ANEB) Stock Analyst Ratings
NASDAQ:ANEB - Nasdaq - US0345691036 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to ANEB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.61. This target is 419.44% above the current price.
ANEB was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ANEB.
In the previous month the buy percentage consensus was at a similar level.
ANEB was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-15 | Maxim Group | Maintains | Buy -> Buy |
| 2024-11-19 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-10-01 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-10-03 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-09-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-21 | Maxim Group | Initiate | Buy |
| 2023-09-18 | HC Wainwright & Co. | Initiate | Buy |
| 2023-05-18 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-02-14 | Benchmark | Maintains | Speculative Buy |
| 2022-07-27 | Ladenburg Thalmann | Initiate | Buy |
| 2021-05-25 | Benchmark | Initiate | Buy |